INS and type 2 diabetes mellitus: Metabolic stress and AMPK inhibit mTORC1 activity (Section 3.1), thereby enhancing the glycemic effects of insulin (Section 3.3), while suppressing insulin action in driving the non-glycemic diseases of T2D (Section 3.4).